Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6596-6606

  Al Sadi, Rana ^a   Guo, Shuhong ^a   Ye, Dongmei ^a   Dokladny, Karol ^a   Alhmoud, Tarik ^a   Ereifej, Lisa ^a   Said, Hamid M ^b,c   Ma, Thomas Y ^a,d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN LIGHT CHAIN KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GENE ACTIVITY; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; MLCK GENE; MOLECULAR MECHANICS; MOUSE; MUTATION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MICE; MYOSIN-LIGHT-CHAIN KINASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIGHT JUNCTIONS; TRANSFECTION;

EID: 84879114381     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201876     Document Type: Article

References (65)

1. Arrieta, M. C., K. Madsen, J. Doyle, and J. Meddings. 2009. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58: 41-48.
2. Hollander, D. 1999. Intestinal permeability, leaky gut, and intestinal disorders. Curr. Gastroenterol. Rep. 1: 410-416.
3. Turner, J. R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9: 799-809.
4. Ma, T. Y., and J. M. Anderson. 2012. Tight junctions and the intestinal barrier. In Physiology of the Gastrointestinal Tract. L. Johnson, ed. Elsevier Academic Press, Burlington, MA, p. 1043-1088.
5. Hollander, D. 1988. Crohn's disease: a permeability disorder of the tight junction? Gut 29: 1621-1624.
6. Arnott, I. D., D. Watts, and S. Ghosh. 2002. Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease? Aliment. Pharmacol. Ther. 16: 857-867. (Pubitemid 34461753)
7. Madsen, K. L. 2001. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin. Invest. Med. 24: 250-257. (Pubitemid 33097303)
8. Madsen, K. L., D. Malfair, D. Gray, J. S. Doyle, L. D. Jewell, and R. N. Fedorak. 1999. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm. Bowel Dis. 5: 262-270.
9. Cominelli, F., C. C. Nast, B. D. Clark, R. Schindler, R. Lierena, V. E. Eysselein, R. C. Thompson, and C. A. Dinarello. 1990. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86: 972-980. (Pubitemid 20327390)
10. Dinarello, C. A. 1994. Interleukin-1 in disease. Keio J. Med. 43: 131-136. (Pubitemid 24318457)
11. Al-Sadi, R. M., and T. Y. Ma. 2007. IL-1β causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178: 4641-4649. (Pubitemid 46492417)
12. Cominelli, F., and T. T. Pizarro. 1996. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10(Suppl 2): 49-53, discussion 54.
13. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147. (Pubitemid 26086851)
14. O'Neill, L. A., and C. A. Dinarello. 2000. The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21: 206-209. (Pubitemid 30259023)
15. Nemetz, A., M. P. Nosti-Escanilla, T. Molnár, A. Köpe, A. Kovács, J. Fehér, Z. Tulassay, F. Nagy, M. A. García- González, and A. S. Peña. 1999. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 49: 527-531. (Pubitemid 29221785)
16. Carvalho, F. A., J. D. Aitken, A. T. Gewirtz, and M. Vijay-Kumar. 2011. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunol. 4: 102-111.
17. Hultgren, O. H., M. Berglund, M. Bjursten, and E. Hultgren Hörnquist. 2006. Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Gαi2-deficient mice. World J. Gastroenterol. 12: 621-624. (Pubitemid 43380795)
18. Carter, J. D., J. Valeriano, and F. B. Vasey. 2003. Crohn disease worsened by anakinra administration. J. Clin. Rheumatol. 9: 276-277. (Pubitemid 36961207)
19. Alten, R., H. Gram, L. A. Joosten, W. B. van den Berg, J. Sieper, S. Wassenberg, G. Burmester, P. van Riel, M. Diaz-Lorente, G. J. Bruin, et al. 2008. The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res. Ther. 10: R67.
20. Brun, P., I. Castagliuolo, V. Di Leo, A. Buda, M. Pinzani, G. Palù, and D. Martines. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G518-G525.
21. Jin, W., H. Wang, Y. Ji, Q. Hu, W. Yan, G. Chen, and H. Yin. 2008. Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. Cytokine 44: 135-140.
22. Al-Sadi, R., M. Boivin, and T. Ma. 2009. Mechanism of cytokine modulation of epithelial tight junction barrier. Front. Biosci. 14: 2765-2778.
23. Al-Sadi, R., D. Ye, K. Dokladny, and T. Y. Ma. 2008. Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability. J. Immunol. 180: 5653-5661.
24. Al-Sadi, R., D. Ye, H. M. Said, and T. Y. Ma. 2011. Cellular and molecular mechanism of interleukin-1β modulation of Caco-2 intestinal epithelial tight junction barrier. J. Cell. Mol. Med. 15: 970-982.
25. Lu, D. Q., J. X. Bei, L. N. Feng, Y. Zhang, X. C. Liu, L. Wang, J. L. Chen, and H. R. Lin. 2008. Interleukin-1β gene in orange-spotted grouper, Epinephelus coioides: molecular cloning, expression, biological activities and signal transduction. Mol. Immunol. 45: 857-867. (Pubitemid 350019504)
26. Armstrong, M. E., C. E. Loscher, M. A. Lynch, and K. H. Mills. 2003. IL-1β-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity. J. Neuroimmunol. 136: 25-33. (Pubitemid 36298841)
27. Boivin, M. A., D. Ye, J. C. Kennedy, R. Al-Sadi, C. Shepela, and T. Y. Ma. 2007. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G590-G598.
28. Clayburgh, D. R., T. A. Barrett, Y. Tang, J. B. Meddings, L. J. Van Eldik, D. M. Watterson, L. L. Clarke, R. J. Mrsny, and J. R. Turner. 2005. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J. Clin. Invest. 115: 2702-2715. (Pubitemid 41434398)
29. Al-Sadi, R., K. Khatib, S. Guo, D. Ye, M. Youssef, and T. Ma. 2011. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 300: G1054-G1064.
30. Clayburgh, D. R., S. Rosen, E. D. Witkowski, F. Wang, S. Blair, S. Dudek, J. G. Garcia, J. C. Alverdy, and J. R. Turner. 2004. A differentiation- dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J. Biol. Chem. 279: 55506-55513. (Pubitemid 40066552)
31. Ye, D., S. Guo, R. Al-Sadi, and T. Y. Ma. 2011. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 141: 1323-1333.
32. Ma, T. Y., G. K. Iwamoto, N. T. Hoa, V. Akotia, A. Pedram, M. A. Boivin, and H. M. Said. 2004. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G367-G376. (Pubitemid 38250308)
33. Kumar, S., P. C. McDonnell, R. J. Gum, A. T. Hand, J. C. Lee, and P. R. Young. 1997. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235: 533-538. (Pubitemid 27326515)
34. Arana-Argáez, V. E., V. Delgado-Rizo, O. E. Pizano- Martínez, E. A. Martínez-Garcia, B. T. Martín- Márquez, A. Muñoz-Gómez, M. H. Petri, J. Armendáriz-Borunda, G. Espinosa-Ramírez, D. A. Zúñiga-Tamayo, et al. 2010. Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1β-induced up-regulation of SRP72 autoantigen in Jurkat cells. J. Biol. Chem. 285: 32824-32833.
35. Kim, Y. J., S. Y. Hwang, E. S. Oh, S. Oh, and I. O. Han. 2006. IL-1β, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-κB pathways. J. Neurosci. Res. 84: 1037-1046. (Pubitemid 44521048)
36. Ahmad, R., J. Sylvester, and M. Zafarullah. 2007. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation. Cell. Signal. 19: 2549-2557. (Pubitemid 47531934)
37. Rossa, C., K. Ehmann, M. Liu, C. Patil, and K. L. Kirkwood. 2006. MKK3/6-p38 MAPK signaling is required for IL-1β and TNF-α-induced RANKL expression in bone marrow stromal cells. J. Interferon Cytokine Res. 26: 719-729. (Pubitemid 44934111)
38. Gan, H. T., and J. D. Chen. 2007. Induction of heme oxygenase-1 improves impaired intestinal transit after burn injury. Surgery 141: 385-393. (Pubitemid 46371308)
39. Saldeen, J., J. C. Lee, and N. Welsh. 2001. Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis. Biochem. Pharmacol. 61: 1561-1569. (Pubitemid 32476910)
40. Yang, C. M., H. L. Hsieh, and C. W. Lee. 2005. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med. J. 28: 813-823.
41. Holden, N. S., M. C. Catley, L. M. Cambridge, P. J. Barnes, and R. Newton. 2004. ICAM-1 expression is highly NF-κB-dependent in A549 cells. No role for ERK and p38 MAPK. Eur. J. Biochem. 271: 785-791. (Pubitemid 38250922)
42. Kacimi, R., J. S. Karliner, F. Koudssi, and C. S. Long. 1998. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ. Res. 82: 576-586. (Pubitemid 28129028)
43. Krishnaveni, M., and S. Jayachandran. 2009. Inhibition of MAP kinases and down regulation of TNF-α, IL-β and COX-2 genes by the crude extracts from marine bacteria. Biomed. Pharmacother. 63: 469-476.
44. Liang, K. C., C. W. Lee, W. N. Lin, C. C. Lin, C. B. Wu, S. F. Luo, and C. M. Yang. 2007. Interleukin-1β induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-κB signaling pathways in human tracheal smooth muscle cells. J. Cell. Physiol. 211: 759-770.
45. Masamune, A., M. Satoh, K. Kikuta, Y. Sakai, A. Satoh, and T. Shimosegawa. 2003. Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells. J. Pharmacol. Exp. Ther. 304: 8-14. (Pubitemid 36008906)
46. Jackson, J. R., B. Bolognese, L. Hillegass, S. Kassis, J. Adams, D. E. Griswold, and J. D. Winkler. 1998. Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J. Pharmacol. Exp. Ther. 284: 687-692. (Pubitemid 28086659)
47. Docena, G., L. Rovedatti, L. Kruidenier, A. Fanning, N. A. Leakey, C. H. Knowles, K. Lee, F. Shanahan, K. Nally, P. G. McLean, et al. 2010. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. Clin. Exp. Immunol. 162: 108-115.
48. Waetzig, G. H., D. Seegert, P. Rosenstiel, S. Nikolaus, and S. Schreiber. 2002. p38 Mitogen-activated protein kinase is activated and linked to TNF-α signaling in inflammatory bowel disease. J. Immunol. 168: 5342-5351. (Pubitemid 34496003)
49. Wang, Q., X. L. Guo, D. Wells-Byrum, G. Noel, T. A. Pritts, and C. K. Ogle. 2008. Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured Caco-2 cells. Shock 29: 531-537. (Pubitemid 351416808)
50. Costantini, T. W., C. Y. Peterson, L. Kroll, W. H. Loomis, B. P. Eliceiri, A. Baird, V. Bansal, and R. Coimbra. 2009. Role of p38 MAPK in burn-induced intestinal barrier breakdown. J. Surg. Res. 156: 64-69.
51. Oshima, T., H. Miwa, and T. Joh. 2008. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am. J. Physiol. Cell Physiol. 295: C800-C806.
52. Patrick, D. M., A. K. Leone, J. J. Shellenberger, K. A. Dudowicz, and J. M. King. 2006. Proinflammatory cytokines tumor necrosis factor-α and interferon-γ modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol. 6: 2.
53. Kevil, C. G., T. Oshima, and J. S. Alexander. 2001. The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium 8: 107-116. (Pubitemid 32821322)
54. Campbell, M., R. Collery, A. McEvoy, T. A. Gardiner, A. W. Stitt, and B. Brankin. 2006. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function. Curr. Eye Res. 31: 1033-1045. (Pubitemid 46005570)
55. - secretion in intestinal epithelia. Am. J. Physiol. 277: C441-C447.
56. Ma, T. Y., N. T. Hoa, D. D. Tran, V. Bui, A. Pedram, S. Mills, and M. Merryfield. 2000. Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G875-G885.
57. Ma, T. Y., D. Nguyen, V. Bui, H. Nguyen, and N. Hoa. 1999. Ethanol modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. 276: G965-G974. (Pubitemid 29214111)
58. Ma, T. Y., D. Tran, N. Hoa, D. Nguyen, M. Merryfield, and A. Tarnawski. 2000. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc. Res. Tech. 51: 156-168.
59. Madara, J. L., R. Moore, and S. Carlson. 1987. Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction. Am. J. Physiol. 253: C854-C861.
60. Turner, J. R., B. K. Rill, S. L. Carlson, D. Carnes, R. Kerner, R. J. Mrsny, and J. L. Madara. 1997. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273: C1378-C1385.
61. Ye, D., I. Ma, and T. Y. Ma. 2006. Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G496-G504.
62. Al-Sadi, R., D. Ye, H. M. Said, and T. Y. Ma. 2010. IL-1β-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-κB pathway. Am. J. Pathol. 177: 2310-2322.
63. Gupta, S., D. Campbell, B. Dérijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393.
64. Livingstone, C., G. Patel, and N. Jones. 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14: 1785-1797.
65. Ricote, M., I. García-Tuñón, F. Bethencourt, B. Fraile, P. Onsurbe, R. Paniagua, and M. Royuela. 2006. The p38 transduction pathway in prostatic neoplasia. J. Pathol. 208: 401-407. (Pubitemid 43210527) Kidney Diseases Kidney Diseases